Links
Organizations
Conferences
Info & Opinion
October 7, 2008
A Tale Of Two CROs
Pfizer Tackles Clinical Efficiency
With impressive numbers, Pfizer’s Mike Collins talked about how the company is streamlining its clinical trial process.
Who Should Not Recruit?
Clarification: Pfizer Site Strategy
A clarification to recent ClinPage coverage of Pfizer at DIA.
- Home
- Tag
- pfizer
Our notebook still has a few gems from IIR’s Clinical Technology ("CTECH") conference, held last month in Philadelphia, which was where we heard Jane Clarke from Wyeth speak. One highlight is a presentation by Pfizer’s Mike Collins. A VP of…
After a complaint from Pfizer, we’ve updated a recent story about DIA. There’s a link to our first story at the bottom of this article. It’s clear ClinPage accurately quoted Andy Lee, Pfizer’s vice president of clinical study and data…
Editor’s note: This story has been revised since it was posted on June 29, 2007. Contrary to our initial article, Pfizer has never asked any site to choose between working for Pfizer and another sponsor. As it explained at DIA,…
Specialty pharma Cobalis will delay reporting trial results because of concerns about the quality of data from electronic patient diaries. Cobalis’s two similar Phase III allergy trials had a total of 1,551 patients and 23 sites. Here’s a quote from…
A largely cryptic news release from a relatively unknown (in the U.S.) firm, Cardiff, has won the company’s “data capture” business. To quote the release: “Cardiff, a division of Autonomy Corporation and leading provider of intelligent document solutions, today announced…
